India’s minimally invasive glaucoma surgery market is set for steady growth through 2033, driven by rising glaucoma cases, expanding eye care access.
ALISO VIEJO, Calif.--(BUSINESS WIRE)-- Glaukos Corporation (GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal ...
India accounted for nearly 22% of APAC's minimally invasive glaucoma surgery market in 2026. India’s minimally invasive ...